Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Laboratory Services

 

Covid: The double whammy – who will be left standing?

In a recent paper on the medtech outlook for Europe, UBS, looked at how Singapore and Toronto bounced back from pandemics. Pent up demand simply led to double growth rates the year after. But Covid is two things: a pandemic coupled to a steep recession, almost certainly worse than 2008. We look at what this means for a sector where private equity has often geared up to the hilt.
April 16, 2020

Labs stand to lose at least third of routine testing volumes

Labs across Europe are set to lose at best a third and at worst all of their routine testing volumes as healthcare systems narrow their focus on coronavirus and patients stay away. The picture is even bleaker for imaging groups.
April 2, 2020

Biogroup buys Laborizon

French lab network group Biogroup LCD will hold 20% of its domestic private lab market following its latest acquisition, CEO Stephane Eimer tells HBI. The deal is likely to be one of the last before M&A grinds to a halt.
April 2, 2020

Exclusive prediction: Pandemic reaching turning point in Europe?

An exclusive analysis by Chinese insurance giant Ping An suggests COVID-19 cases could reach a turning point in the next few days, hitting the peak of new confirmed cases by later this week / early April,  with that figure set to fall thereafter.
March 30, 2020

Investor launches buyout of Nigeria’s third-largest diagnostics chain

Listed Nigerian lab and imaging group Union Diagnostics, the country's third-largest by revenue, is the target of a majority buyout by its largest single shareholder. We talk to a well-placed source about the Nigerian diagnostics market which has five big players, including European and GCC diagnostic operators Synlab, IDH and Cerba which entered recently. 
March 25, 2020
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us